Analyst Price Targets — FMS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 6, 2026 12:03 pm | Susannah Ludwig | Bernstein | $25.80 | $24.19 | TheFly | Fresenius Medical price target raised to $25.80 from $25.50 at Bernstein |
| August 5, 2026 12:43 pm | — | Truist Financial | $25.00 | $23.59 | TheFly | Fresenius Medical price target lowered to $25 from $26 at Truist |
| July 28, 2026 8:34 am | — | BNP Paribas | $19.90 | $24.87 | TheFly | Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas |
| January 5, 2026 12:19 pm | — | Truist Financial | $28.00 | $23.51 | TheFly | Fresenius Medical price target raised to $28 from $26 at Truist |
| May 15, 2024 9:07 am | David MacDonald | Truist Financial | $24.00 | $22.48 | TheFly | Fresenius Medical price target raised to $24 from $21 at Truist |
| January 2, 2023 7:30 pm | James Vane-Tempest | Jefferies | $11.70 | $16.34 | TheFly | Fresenius Medical downgraded to Underperform from Buy at Jefferies |
| June 22, 2022 7:28 am | — | Truist Financial | $27.00 | $23.64 | Benzinga | Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $27 |
Latest News for FMS
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $23.13 and traded as high as $23.92. Fresenius Medical Care AG and Co. KGaA shares last traded at $23.43,
These stocks have economic moats and look attractive today.
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS) reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year outlook despite weaker U.S. treatment volumes and anticipated reimbursement-related headwinds in the second half. Chief Executive Officer Helen Giza said the company's operating-income growth accelerated
FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.
Silicon Motion Technology Corporation (NasdaqGS: SIMO) (âSilicon Motionâ), a global leader in designing and marketing NAND flash controllers for solid-state
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FMS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.